Unknown

Dataset Information

0

No Differences in Value-Based Decision-Making Due to Use of Oral Contraceptives.


ABSTRACT: Fluctuating ovarian hormones have been shown to affect decision-making processes in women. While emerging evidence suggests effects of endogenous ovarian hormones such as estradiol and progesterone on value-based decision-making in women, the impact of exogenous synthetic hormones, as in most oral contraceptives, is not clear. In a between-subjects design, we assessed measures of value-based decision-making in three groups of women aged 18 to 29 years, during (1) active oral contraceptive intake (N = 22), (2) the early follicular phase of the natural menstrual cycle (N = 20), and (3) the periovulatory phase of the natural menstrual cycle (N = 20). Estradiol, progesterone, testosterone, and sex-hormone binding globulin levels were assessed in all groups via blood samples. We used a test battery which measured different facets of value-based decision-making: delay discounting, risk-aversion, risk-seeking, and loss aversion. While hormonal levels did show the expected patterns for the three groups, there were no differences in value-based decision-making parameters. Consequently, Bayes factors showed conclusive evidence in support of the null hypothesis. We conclude that women on oral contraceptives show no differences in value-based decision-making compared to the early follicular and periovulatory natural menstrual cycle phases.

SUBMITTER: Lewis CA 

PROVIDER: S-EPMC9075610 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

No Differences in Value-Based Decision-Making Due to Use of Oral Contraceptives.

Lewis Carolin A CA   Kimmig Ann-Christin S AS   Kroemer Nils B NB   Pooseh Shakoor S   Smolka Michael N MN   Sacher Julia J   Derntl Birgit B  

Frontiers in endocrinology 20220422


Fluctuating ovarian hormones have been shown to affect decision-making processes in women. While emerging evidence suggests effects of endogenous ovarian hormones such as estradiol and progesterone on value-based decision-making in women, the impact of exogenous synthetic hormones, as in most oral contraceptives, is not clear. In a between-subjects design, we assessed measures of value-based decision-making in three groups of women aged 18 to 29 years, during (1) active oral contraceptive intake  ...[more]

Similar Datasets

| S-EPMC8993860 | biostudies-literature
| S-EPMC4992126 | biostudies-literature
| S-EPMC10714696 | biostudies-literature
| S-EPMC11208973 | biostudies-literature
| S-EPMC4833575 | biostudies-literature
| S-EPMC11574977 | biostudies-literature
| S-EPMC8643324 | biostudies-literature
| S-EPMC6218187 | biostudies-literature
| S-EPMC10994558 | biostudies-literature
| S-EPMC6057456 | biostudies-literature